Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Re-Intervention (ERI) Experiment 2

NCT01153594 is registered in ClinicalTrials.gov with Chestnut Health Systems as lead sponsor.

NCT NCT01153594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01153594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Re-Intervention (ERI) Experiment 2
Lead sponsor
Chestnut Health Systems
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2004
Completion date
June 30, 2009
Enrollment
446 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

substance use disorders